Chemed Corporation (CHE)
$
368.59
-3.36 (-0.91%)
Key metrics
Financial statements
Free cash flow per share
23.2583
Market cap
5.2 Billion
Price to sales ratio
2.0555
Debt to equity
0.1580
Current ratio
1.0539
Income quality
1.4639
Average inventory
7.9 Million
ROE
0.2392
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The net total of other income and expenses is $17,532,000.00 reflecting non-core financial activities. The total costs and expenses for the company are $2,191,732,000.00 reflecting its overall spending. Additionally, the net income ratio is 0.10 reflecting the company's profitability margin. The company earned an interest income of $8,745,000.00 showcasing its financial investments. It operates in two segments: VITAS, focused on healthcare services, and Roto-Rooter, which provides plumbing and related services. The company's stock is identified with the symbol 'CHE' in the market, representing its presence within the competitive landscape. With its foundation dating back to 1970 and headquartered in Cincinnati, Ohio, Chemed Corporation continues to adapt and thrive in its service offerings. The stock is priced at $452.25 positioning it in the higher-end market, indicative of its perceived value among investors. However, the stock has a low average trading volume of 207,552.00 indicating lower market activity, which may suggest a niche interest. With a mid-range market capitalization of $5,200,404,980.00 the company is a steady performer in the financial landscape. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape and ensuring a diverse range of service offerings. Furthermore, it belongs to the Healthcare sector, driving innovation and growth within its fields of expertise while maintaining a solid reputation among its peers and stakeholders.
Is Chemed Corporation (CHE) a good investment?
Investing in Chemed Corporation (CHE) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bearish outlook. Always conduct your own research before investing.
What is Chemed Corporation (CHE)'s stock forecast?
Analysts predict Chemed Corporation stock to fluctuate between $365.25 (low) and $623.61 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Chemed Corporation's market capitalization?
As of 2026-03-27, Chemed Corporation's market cap is $5,200,404,980, based on 14,108,915 outstanding shares.
How does Chemed Corporation compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Chemed Corporation has a Lower Market-Cap, indicating a difference in performance.
Does Chemed Corporation pay dividends?
Chemed Corporation pays dividends. The current dividend yield is 0.48%, with a payout of $0.60 per share.
How can I buy Chemed Corporation (CHE) stock?
To buy Chemed Corporation (CHE) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CHE. Place an order (Market, Limit, etc.).
What is the best time to invest in Chemed Corporation?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Has Chemed Corporation stock ever split?
Chemed Corporation's last stock split was 2:1 on 2005-05-12.
How did Chemed Corporation perform in the last earnings report?
Revenue: $2,529,978,000 | EPS: $18.42 | Growth: -8.36%.
Where can I find Chemed Corporation's investor relations reports?
Visit https://www.chemed.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Chemed Corporation?
You can explore historical data from here
What is the all-time high and low for Chemed Corporation stock?
All-time high: $654.62 (2024-03-15) | All-time low: $365.21 (2026-03-27).
What are the key trends affecting Chemed Corporation stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
seekingalpha.com
Chemed Corporation (CHE) Presents at Oppenheimer 36th Annual Healthcare MedTech & Services Conference Transcript
zacks.com
Chemed slips 15% as Q4 earnings and revenue missed estimates, margins contracted, and the 2026 EPS outlook fell short of consensus.
seekingalpha.com
Chemtrade Logistics Income Fund (CHE.UN:CA) Q4 2025 Earnings Call Transcript
globenewswire.com
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Chemed Corporation (NYSE: CHE). The investigation focuses on Chemed's executive officers and whether investor losses may be recovered under federal securities laws.
fool.com
Barington Companies Management initiated a 13,000-share position in Chemed during the fourth quarter. The estimated trade value was $5.56 million.
globenewswire.com
CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.
globenewswire.com
CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange.
zacks.com
CHE shows growth momentum from VITAS and resilient Roto-Rooter results, but macro headwinds and competition continue to cloud its near-term outlook.
zacks.com
Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
See all news
